Matches in Wikidata for { <http://www.wikidata.org/entity/Q88663272> ?p ?o ?g. }
- Q88663272 description "article scientifique publié en 2018" @default.
- Q88663272 description "artículu científicu espublizáu en payares de 2018" @default.
- Q88663272 description "im November 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q88663272 description "scientific article published on 01 November 2018" @default.
- Q88663272 description "wetenschappelijk artikel" @default.
- Q88663272 description "наукова стаття, опублікована в листопаді 2018" @default.
- Q88663272 name "Utilizing T-cell Activation Signals 1, 2, and 3 for Tumor-infiltrating Lymphocytes (TIL) Expansion: The Advantage Over the Sole Use of Interleukin-2 in Cutaneous and Uveal Melanoma" @default.
- Q88663272 name "Utilizing T-cell Activation Signals 1, 2, and 3 for Tumor-infiltrating Lymphocytes (TIL) Expansion: The Advantage Over the Sole Use of Interleukin-2 in Cutaneous and Uveal Melanoma" @default.
- Q88663272 type Item @default.
- Q88663272 label "Utilizing T-cell Activation Signals 1, 2, and 3 for Tumor-infiltrating Lymphocytes (TIL) Expansion: The Advantage Over the Sole Use of Interleukin-2 in Cutaneous and Uveal Melanoma" @default.
- Q88663272 label "Utilizing T-cell Activation Signals 1, 2, and 3 for Tumor-infiltrating Lymphocytes (TIL) Expansion: The Advantage Over the Sole Use of Interleukin-2 in Cutaneous and Uveal Melanoma" @default.
- Q88663272 prefLabel "Utilizing T-cell Activation Signals 1, 2, and 3 for Tumor-infiltrating Lymphocytes (TIL) Expansion: The Advantage Over the Sole Use of Interleukin-2 in Cutaneous and Uveal Melanoma" @default.
- Q88663272 prefLabel "Utilizing T-cell Activation Signals 1, 2, and 3 for Tumor-infiltrating Lymphocytes (TIL) Expansion: The Advantage Over the Sole Use of Interleukin-2 in Cutaneous and Uveal Melanoma" @default.
- Q88663272 P1433 Q88663272-A296554F-9FFD-4F33-82F0-3E1778EB429E @default.
- Q88663272 P1476 Q88663272-8F7F3EFD-20FB-4F8C-9052-866E8E94CE93 @default.
- Q88663272 P2093 Q88663272-1DA9B4B8-14ED-43DF-AF08-DC6EADB2C689 @default.
- Q88663272 P2093 Q88663272-5234A384-87D0-4620-B5A8-693842035A2F @default.
- Q88663272 P2093 Q88663272-77E94927-C0CB-43F6-A916-01B1FDE83DD9 @default.
- Q88663272 P2093 Q88663272-CB3D0845-A484-4947-AB09-F99B2BC483A1 @default.
- Q88663272 P2093 Q88663272-EE387CAE-5BCA-4F35-8187-0EA600390745 @default.
- Q88663272 P2860 Q88663272-08DC1D2D-AD15-447D-9B4D-ACC041BBB7CE @default.
- Q88663272 P2860 Q88663272-2838CAE8-25E1-4422-9E25-CC005ABF3172 @default.
- Q88663272 P2860 Q88663272-29BFBEF6-82A3-468E-9562-112728922840 @default.
- Q88663272 P2860 Q88663272-302BA5F1-5DAF-4D91-91DF-97522198AE27 @default.
- Q88663272 P2860 Q88663272-3C090C21-7FD6-4EF6-B45E-733B120F0EA8 @default.
- Q88663272 P2860 Q88663272-3CA072B3-F1E5-41CA-BBE8-ABB8067E8927 @default.
- Q88663272 P2860 Q88663272-4B8575A9-A9C4-4ACA-8D16-4F64E034F40E @default.
- Q88663272 P2860 Q88663272-60FB010D-D1B6-42A2-8997-2AEDA309A912 @default.
- Q88663272 P2860 Q88663272-66928B2C-D5A5-42A8-88C4-CEF9AC20DE4E @default.
- Q88663272 P2860 Q88663272-67A21DE1-FD42-4452-8C7B-ADF9527DAF21 @default.
- Q88663272 P2860 Q88663272-6E01B412-73D2-435B-BEA9-075C5DDF72BA @default.
- Q88663272 P2860 Q88663272-7309BC8C-4DA8-4049-A1A9-8870C67847A8 @default.
- Q88663272 P2860 Q88663272-98017FA1-FA87-4AD5-9594-BA323233AA4C @default.
- Q88663272 P2860 Q88663272-9BF3621C-BD16-4B66-8DEC-EDF263720790 @default.
- Q88663272 P2860 Q88663272-AF1DE91E-3F21-4D38-A6D7-397A1D79DB75 @default.
- Q88663272 P2860 Q88663272-BD4D0F72-EF7E-415A-ACA1-0D3ECB20EFBB @default.
- Q88663272 P2860 Q88663272-BED70175-361F-4F58-89B3-2F0EA9509C10 @default.
- Q88663272 P2860 Q88663272-CEDCBC74-71E3-4910-902D-080575E8D99A @default.
- Q88663272 P2860 Q88663272-F2BF6698-FBC2-47C4-B7AD-5FC9EFB2AC2D @default.
- Q88663272 P2860 Q88663272-FB63E3BB-DA09-4A9A-A05B-C7956DFAA481 @default.
- Q88663272 P2860 Q88663272-FDBF100E-D82B-46E4-8DF0-E5A15A0E5DE3 @default.
- Q88663272 P304 Q88663272-C724163A-FBA6-48BC-A92B-6786D9C09BE1 @default.
- Q88663272 P31 Q88663272-4EC6EEFD-CD7E-4CBF-9ADC-F24F89181CEA @default.
- Q88663272 P356 Q88663272-212202C1-1683-48F8-999C-66BE09009484 @default.
- Q88663272 P433 Q88663272-370C3BD4-1E0B-4857-AFEC-DE56AE55F978 @default.
- Q88663272 P478 Q88663272-8C9B427F-FC47-4006-AF57-39C3969C6489 @default.
- Q88663272 P50 Q88663272-009D5C91-15C7-48FF-8A34-14896C722324 @default.
- Q88663272 P50 Q88663272-0E5E6182-96E9-4CCD-9299-D69D3DAB0BF5 @default.
- Q88663272 P50 Q88663272-1DA1D76A-0261-40B0-A185-2B8091758FA7 @default.
- Q88663272 P50 Q88663272-22DDB7F6-6B14-4648-A672-98CCDE16722D @default.
- Q88663272 P50 Q88663272-28A7464C-93DA-4A94-97EC-340698D71638 @default.
- Q88663272 P50 Q88663272-34FFFCDF-8210-4038-BF30-1F6F2B87EF05 @default.
- Q88663272 P50 Q88663272-36D2BE32-E1BA-41BC-BAB7-44D5FCC1DD0E @default.
- Q88663272 P50 Q88663272-389759F7-FE13-479C-B401-4B077C651557 @default.
- Q88663272 P50 Q88663272-3BA8E768-C157-498E-8F9C-2D60C99E24EA @default.
- Q88663272 P50 Q88663272-4B44BCB0-2001-451A-A247-BE204AC5E6DF @default.
- Q88663272 P50 Q88663272-670353F7-1F24-4460-A769-B241D6F501BA @default.
- Q88663272 P50 Q88663272-7CAB2EB6-D94B-42B1-B048-A5596B2F95FE @default.
- Q88663272 P50 Q88663272-AD8CB0AE-031D-420B-AFC8-675150E94030 @default.
- Q88663272 P50 Q88663272-C0F934D9-B86C-4731-BC94-EE750A900846 @default.
- Q88663272 P50 Q88663272-CA47D04C-2E55-41F0-ABE7-22108D221F3D @default.
- Q88663272 P50 Q88663272-EA61A4B7-FE5F-45CF-AFB2-2E8C588ACDB5 @default.
- Q88663272 P50 Q88663272-FC0A3D7E-CA5D-4B87-B098-869488D09CEC @default.
- Q88663272 P577 Q88663272-54509704-E7FC-438C-931E-A7E7E601834F @default.
- Q88663272 P698 Q88663272-89BC9AF4-9A41-420B-8D33-C918317DBC77 @default.
- Q88663272 P921 Q88663272-56AF0702-9257-4B79-9EFE-121E993ECEDA @default.
- Q88663272 P932 Q88663272-177143F5-B8B8-41FD-8F93-B606CDE33603 @default.
- Q88663272 P356 CJI.0000000000000230 @default.
- Q88663272 P698 29757889 @default.
- Q88663272 P1433 Q15763946 @default.
- Q88663272 P1476 "Utilizing T-cell Activation Signals 1, 2, and 3 for Tumor-infiltrating Lymphocytes (TIL) Expansion: The Advantage Over the Sole Use of Interleukin-2 in Cutaneous and Uveal Melanoma" @default.
- Q88663272 P2093 "Esteban Flores" @default.
- Q88663272 P2093 "Laszlo G Radvanyi" @default.
- Q88663272 P2093 "Marie-Andrée Forget" @default.
- Q88663272 P2093 "Sapna P Patel" @default.
- Q88663272 P2093 "Young Uk Kim" @default.
- Q88663272 P2860 Q24548019 @default.
- Q88663272 P2860 Q24598792 @default.
- Q88663272 P2860 Q29617771 @default.
- Q88663272 P2860 Q33440852 @default.
- Q88663272 P2860 Q33839273 @default.
- Q88663272 P2860 Q34111120 @default.
- Q88663272 P2860 Q34350259 @default.
- Q88663272 P2860 Q34656292 @default.
- Q88663272 P2860 Q35563824 @default.
- Q88663272 P2860 Q36060241 @default.
- Q88663272 P2860 Q36710982 @default.
- Q88663272 P2860 Q37346107 @default.
- Q88663272 P2860 Q38394457 @default.
- Q88663272 P2860 Q42126236 @default.
- Q88663272 P2860 Q42483747 @default.
- Q88663272 P2860 Q43129884 @default.
- Q88663272 P2860 Q46757961 @default.
- Q88663272 P2860 Q46863819 @default.
- Q88663272 P2860 Q50147228 @default.
- Q88663272 P2860 Q54139665 @default.
- Q88663272 P2860 Q57152489 @default.
- Q88663272 P304 "399-405" @default.
- Q88663272 P31 Q13442814 @default.
- Q88663272 P356 "10.1097/CJI.0000000000000230" @default.